Nine years ago I embarked on a weight-loss mission. I shed four-and-a-half stone walking four miles a day and doing an hour ...

Medications originally designed to treat obesity and diabetes may also dramatically cut the risk of serious heart problems. A ...

Regeneron Pharmaceuticals, Inc.’s pharma pipeline and $20bn revenue potential promise long-term upside, despite a recent ...

Amylyx Pharmaceuticals, Inc. ( NASDAQ: AMLX) Citi's Biopharma Back to School Conference September 2, 2025 1:00 PM EDT ...

California's decision to cut off access to anti-obesity drugs may backfire, leading to increased health care spending in the ...

You may not have heard the term ‘GLP-1 agonists’ before, but it’s a broad descriptor for a group of drugs with multiple ...

Eli Lilly is on track to release orforglipron next year, which has showed an average of 12 percent weight loss.

Illinois Gov. JB Pritzker is opening up about his morning routine and weight loss journey, as others take notice that the ...

In line with the effort, J.M. Smucker back in May said it plans to shut its Hostess production plant in Indianapolis and pursue a sale of the facility by the end of 2026.

Teva Pharmaceuticals gained FDA approval to launch the first generic GLP-1 drug for weight loss, a liraglutide injection based on Saxenda.

While a recent head-to-head trial of the obesity med heavyweights Wegovy and Zepbound favored the latter drug from Eli Lilly ...

President Trump urged pharmaceutical companies to publicly prove that their Covid-19 products work, saying in a Truth Social ...